[
  {
    "url": "http://tiaa.org/#item1",
    "text": "TIAA-CREF - Watch TIAA-CREF's Daniel Morris",
    "icon": "icon-arrow-right",
    "summary": "Watch TIAA-CREF's Daniel Morris discuss the potential for the Nasdaq to reach 5,000 on CNBC..."
  },
  {
    "url": "http://tiaa.org/#item2",
    "text": "Plan Sponsor Reporting and Audit Guide",
    "icon": "icon-arrow-right",
    "summary": "Beginning in October 2014, the unit values for the CREF Accounts and TIAA Real Estate Account are"
  },
  {
    "url": "http://tiaa.org/#item3",
    "text": "TIAA-CREF Life Funds Schedules of Investments",
    "icon": "icon-arrow-right",
    "summary": "676,818 22,041 Merck &amp; Co, Inc 1,266,917 75,975 Pfizer, Inc 2,643,170 6,164 * Qiagen NV (<strong>NAS</strong>)"
  },
  {
    "url": "http://tiaa.org/#item4",
    "text": "TIAA-CREF - Watch TIAA-CREF's Daniel Morris",
    "icon": "icon-arrow-right",
    "summary": "Watch TIAA-CREF's Daniel Morris discuss the potential for the Nasdaq to reach 5,000 on CNBC..."
  },
  {
    "url": "http://tiaa.org/#item5",
    "text": "Plan Sponsor Reporting and Audit Guide",
    "icon": "icon-arrow-right",
    "summary": "Beginning in October 2014, the unit values for the CREF Accounts and TIAA Real Estate Account are"
  },
  {
    "url": "http://tiaa.org/#item6",
    "text": "TIAA-CREF - Watch TIAA-CREF's Daniel Morris",
    "icon": "icon-arrow-right",
    "summary": "Watch TIAA-CREF's Daniel Morris discuss the potential for the Nasdaq to reach 5,000 on CNBC..."
  },
  {
    "url": "http://tiaa.org/#item7",
    "text": "Plan Sponsor Reporting and Audit Guide",
    "icon": "icon-arrow-right",
    "summary": "Beginning in October 2014, the unit values for the CREF Accounts and TIAA Real Estate Account are"
  },
  {
    "url": "http://tiaa.org/#item8",
    "text": "TIAA-CREF Life Funds Schedules of Investments",
    "icon": "icon-arrow-right",
    "summary": "676,818 22,041 Merck &amp; Co, Inc 1,266,917 75,975 Pfizer, Inc 2,643,170 6,164 * Qiagen NV (<strong>NAS</strong>"
  },
  {
    "url": "http://tiaa.org/#item9",
    "text": "TIAA-CREF - Watch TIAA-CREF's Daniel Morris",
    "icon": "icon-arrow-right",
    "summary": "Watch TIAA-CREF's Daniel Morris discuss the potential for the Nasdaq to reach 5,000 on CNBC..."
  },
  {
    "url": "http://tiaa.org/#item10",
    "text": "Plan Sponsor Reporting and Audit Guide",
    "icon": "icon-arrow-right",
    "summary": "Beginning in October 2014, the unit values for the CREF Accounts and TIAA Real Estate Account are"
  },
  {
    "url": "http://tiaa.org/#item11",
    "text": "TIAA-CREF - Watch TIAA-CREF's Daniel Morris",
    "icon": "icon-arrow-right",
    "summary": "Watch TIAA-CREF's Daniel Morris discuss the potential for the Nasdaq to reach 5,000 on CNBC..."
  },
  {
    "url": "http://tiaa.org/#item12",
    "text": "Plan Sponsor Reporting and Audit Guide",
    "icon": "icon-arrow-right",
    "summary": "Beginning in October 2014, the unit values for the CREF Accounts and TIAA Real Estate Account are"
  },
  {
    "url": "http://tiaa.org/#item13",
    "text": "TIAA-CREF Life Funds Schedules of Investments",
    "icon": "icon-arrow-right",
    "summary": "676,818 22,041 Merck &amp; Co, Inc 1,266,917 75,975 Pfizer, Inc 2,643,170 6,164 * Qiagen NV (<strong>NAS</strong>"
  },
  {
    "url": "http://tiaa.org/#item14",
    "text": "TIAA-CREF - Watch TIAA-CREF's Daniel Morris",
    "icon": "icon-arrow-right",
    "summary": "Watch TIAA-CREF's Daniel Morris discuss the potential for the Nasdaq to reach 5,000 on CNBC..."
  },
  {
    "url": "http://tiaa.org/#item15",
    "text": "Plan Sponsor Reporting and Audit Guide",
    "icon": "icon-arrow-right",
    "summary": "Beginning in October 2014, the unit values for the CREF Accounts and TIAA Real Estate Account are"
  },
  {
    "url": "http://tiaa.org/#item16",
    "text": "TIAA-CREF - Watch TIAA-CREF's Daniel Morris",
    "icon": "icon-arrow-right",
    "summary": "Watch TIAA-CREF's Daniel Morris discuss the potential for the Nasdaq to reach 5,000 on CNBC..."
  },
  {
    "url": "http://tiaa.org/#item17",
    "text": "Plan Sponsor Reporting and Audit Guide",
    "icon": "icon-arrow-right",
    "summary": "Beginning in October 2014, the unit values for the CREF Accounts and TIAA Real Estate Account are"
  },
  {
    "url": "http://tiaa.org/#item18",
    "text": "TIAA-CREF Life Funds Schedules of Investments",
    "icon": "icon-arrow-right",
    "summary": "676,818 22,041 Merck &amp; Co, Inc 1,266,917 75,975 Pfizer, Inc 2,643,170 6,164 * Qiagen NV (<strong>NAS</strong>"
  },
  {
    "url": "http://tiaa.org/#item19",
    "text": "TIAA-CREF - Watch TIAA-CREF's Daniel Morris",
    "icon": "icon-arrow-right",
    "summary": "Watch TIAA-CREF's Daniel Morris discuss the potential for the Nasdaq to reach 5,000 on CNBC..."
  },
  {
    "url": "http://tiaa.org/#item20",
    "text": "Plan Sponsor Reporting and Audit Guide",
    "icon": "icon-arrow-right",
    "summary": "Beginning in October 2014, the unit values for the CREF Accounts and TIAA Real Estate Account are"
  },
  {
    "url": "http://tiaa.org/#item21",
    "text": "TIAA-CREF - Watch TIAA-CREF's Daniel Morris",
    "icon": "icon-arrow-right",
    "summary": "Watch TIAA-CREF's Daniel Morris discuss the potential for the Nasdaq to reach 5,000 on CNBC..."
  },
  {
    "url": "http://tiaa.org/#item22",
    "text": "Plan Sponsor Reporting and Audit Guide",
    "icon": "icon-arrow-right",
    "summary": "Beginning in October 2014, the unit values for the CREF Accounts and TIAA Real Estate Account are"
  },
  {
    "url": "http://tiaa.org/#item23",
    "text": "TIAA-CREF Life Funds Schedules of Investments",
    "icon": "icon-arrow-right",
    "summary": "676,818 22,041 Merck &amp; Co, Inc 1,266,917 75,975 Pfizer, Inc 2,643,170 6,164 * Qiagen NV (<strong>NAS</strong>"
  },
  {
    "url": "http://tiaa.org/#item24",
    "text": "TIAA-CREF - Watch TIAA-CREF's Daniel Morris",
    "icon": "icon-arrow-right",
    "summary": "Watch TIAA-CREF's Daniel Morris discuss the potential for the Nasdaq to reach 5,000 on CNBC..."
  },
  {
    "url": "http://tiaa.org/#item25",
    "text": "Plan Sponsor Reporting and Audit Guide",
    "icon": "icon-arrow-right",
    "summary": "Beginning in October 2014, the unit values for the CREF Accounts and TIAA Real Estate Account are"
  },
  {
    "url": "http://tiaa.org/#item26",
    "text": "TIAA-CREF - Watch TIAA-CREF's Daniel Morris",
    "icon": "icon-arrow-right",
    "summary": "Watch TIAA-CREF's Daniel Morris discuss the potential for the Nasdaq to reach 5,000 on CNBC..."
  },
  {
    "url": "http://tiaa.org/#item27",
    "text": "Plan Sponsor Reporting and Audit Guide",
    "icon": "icon-arrow-right",
    "summary": "Beginning in October 2014, the unit values for the CREF Accounts and TIAA Real Estate Account are"
  },
  {
    "url": "http://tiaa.org/#item28",
    "text": "TIAA-CREF Life Funds Schedules of Investments",
    "icon": "icon-arrow-right",
    "summary": "676,818 22,041 Merck &amp; Co, Inc 1,266,917 75,975 Pfizer, Inc 2,643,170 6,164 * Qiagen NV (<strong>NAS</strong>"
  },
  {
    "url": "http://tiaa.org/#item29",
    "text": "TIAA-CREF - Watch TIAA-CREF's Daniel Morris",
    "icon": "icon-arrow-right",
    "summary": "Watch TIAA-CREF's Daniel Morris discuss the potential for the Nasdaq to reach 5,000 on CNBC..."
  },
  {
    "url": "http://tiaa.org/#item30",
    "text": "Plan Sponsor Reporting and Audit Guide",
    "icon": "icon-arrow-right",
    "summary": "Beginning in October 2014, the unit values for the CREF Accounts and TIAA Real Estate Account are</span></a></li>"
  }
]